SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Cash who wrote (1471)2/10/1999 6:42:00 PM
From: wlheatmoon  Read Replies (1) of 2135
 
Dr. Folkman is not a hype. He never wanted the attention given to his findings until he had more data. Media wouldn't wait and ENMD rocketed. ENMD is not Dr. Folkman's company. He is a surgeon-researcher at Harvard. His work speaks for themselves. He is one of the most prolific and successful researcher in surgery. ENMD/BMY and the market will do what it will. Dr. Folkman's theory is still plausible, but much more work is required. That's the whole story.
Biotechs is a risky business. That has no bearing on the good doctor.
mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News